Argentina's National Drug, Food and Medical Technology Administration (ANMAT) has issued a resolution forbidding the use of antibacterial substances in products for personal hygiene...

Decree 438/2021 modifies the current regime regarding the free choice of social security companies for employees.

On April 28, 2016, the Joint Ordinary General Assembly for Medical Devices took place in Mexico D.F. organized by the Mexican Pharmaceutical Industry Chamber (CANIFARMA).

On August, 5, 2016, Argentineans were warned about adulterated products for washing clothes by the Argentinean National Administration of Medicines, Food and Medical Technology (ANMAT).

In May 2016, FDA sent the second warning letter to the Argentinian manufacturing medical device company.

On January 13th, 2017, the Official Gazette of Buenos Aires City published Law No. 5709, which aims to provide patients a tool that allows them to have as much information as possible about conflicts...

Laboratories and other healthcare industry companies granting payments and benefits to physicians may face different liabilities under Argentine Law, calling for a cautious...

Employers in Argentina should look closely at cost increases resulting from sweeping reforms that allow healthcare providers to adjust plans' premiums on their own terms.

Argentina has introduced tighter restrictions on travellers entering the country, limiting entry to a very narrow list of individuals and imposing strict testing and quarantine restrictions on most...

Through the enactment of Law No. 5709, the City of Buenos Aires has taken a step forward regarding patient protection and possible conflicts of interest that might affect therapeutic decisions...